The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Neuromuscular Junction

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Neuromuscular Junction


Psychiatry related information on Neuromuscular Junction


High impact information on Neuromuscular Junction


Chemical compound and disease context of Neuromuscular Junction


Biological context of Neuromuscular Junction


Anatomical context of Neuromuscular Junction


Associations of Neuromuscular Junction with chemical compounds


Gene context of Neuromuscular Junction


Analytical, diagnostic and therapeutic context of Neuromuscular Junction


  1. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. Toyka, K.V., Drachman, D.B., Griffin, D.E., Pestronk, A., Winkelstein, J.A., Fishbeck, K.H., Kao, I. N. Engl. J. Med. (1977) [Pubmed]
  2. Ouabain stimulation of noradrenaline transport in guinea pig heart. Sharma, V.K., Pottick, L.A., Banerjee, S.P. Nature (1980) [Pubmed]
  3. Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. Gu, D., Wogensen, L., Calcutt, N.A., Xia, C., Zhu, S., Merlie, J.P., Fox, H.S., Lindstrom, J., Powell, H.C., Sarvetnick, N. J. Exp. Med. (1995) [Pubmed]
  4. Developmental switch in the pharmacology of Ca2+ channels coupled to acetylcholine release. Gray, D.B., Brusés, J.L., Pilar, G.R. Neuron (1992) [Pubmed]
  5. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. Burkin, D.J., Wallace, G.Q., Nicol, K.J., Kaufman, D.J., Kaufman, S.J. J. Cell Biol. (2001) [Pubmed]
  6. Rho is a presynaptic activator of neurotransmitter release at pre-existing synapses in C. elegans. McMullan, R., Hiley, E., Morrison, P., Nurrish, S.J. Genes Dev. (2006) [Pubmed]
  7. Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle. Akaaboune, M., Allinquant, B., Farza, H., Roy, K., Magoul, R., Fiszman, M., Festoff, B.W., Hantaï, D. Mol. Cell. Neurosci. (2000) [Pubmed]
  8. Quantal acetylcholine release at the vertebrate neuromuscular junction. Van der Kloot, W., Molgó, J. Physiol. Rev. (1994) [Pubmed]
  9. Alpha3Na+/K+-ATPase is a neuronal receptor for agrin. Hilgenberg, L.G., Su, H., Gu, H., O'Dowd, D.K., Smith, M.A. Cell (2006) [Pubmed]
  10. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Grady, R.M., Teng, H., Nichol, M.C., Cunningham, J.C., Wilkinson, R.S., Sanes, J.R. Cell (1997) [Pubmed]
  11. Agrin acts via a MuSK receptor complex. Glass, D.J., Bowen, D.C., Stitt, T.N., Radziejewski, C., Bruno, J., Ryan, T.E., Gies, D.R., Shah, S., Mattsson, K., Burden, S.J., DiStefano, P.S., Valenzuela, D.M., DeChiara, T.M., Yancopoulos, G.D. Cell (1996) [Pubmed]
  12. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. DeChiara, T.M., Bowen, D.C., Valenzuela, D.M., Simmons, M.V., Poueymirou, W.T., Thomas, S., Kinetz, E., Compton, D.L., Rojas, E., Park, J.S., Smith, C., DiStefano, P.S., Glass, D.J., Burden, S.J., Yancopoulos, G.D. Cell (1996) [Pubmed]
  13. Adenosine acting at an A1 receptor decreases N-type calcium current in mouse motoneurons. Mynlieff, M., Beam, K.G. J. Neurosci. (1994) [Pubmed]
  14. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Tzartos, S.J., Barkas, T., Cung, M.T., Mamalaki, A., Marraud, M., Orlewski, P., Papanastasiou, D., Sakarellos, C., Sakarellos-Daitsiotis, M., Tsantili, P., Tsikaris, V. Immunol. Rev. (1998) [Pubmed]
  15. Drug actions at mammalian motor nerve endings: the suppression of neostigmine-induced fasciculations by vecuronium and isoflurane. Baker, T., Stanec, A. Anesthesiology (1987) [Pubmed]
  16. Bacterial lipopolysaccharide depresses spontaneous, evoked, and ionophore-induced transmitter release at the neuromuscular junction. Person, R.J. J. Neurosci. Res. (1979) [Pubmed]
  17. Effect of selective diaphragmatic paralysis on the inspiratory motor drive. Teitelbaum, J., Borel, C.O., Magder, S., Traystman, R.J., Hussain, S.N. J. Appl. Physiol. (1993) [Pubmed]
  18. Action potentials must admit calcium to evoke transmitter release. Mulkey, R.M., Zucker, R.S. Nature (1991) [Pubmed]
  19. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Washbourne, P., Thompson, P.M., Carta, M., Costa, E.T., Mathews, J.R., Lopez-Benditó, G., Molnár, Z., Becher, M.W., Valenzuela, C.F., Partridge, L.D., Wilson, M.C. Nat. Neurosci. (2002) [Pubmed]
  20. Regulation of tyrosine phosphorylation of the nicotinic acetylcholine receptor at the rat neuromuscular junction. Qu, Z.C., Moritz, E., Huganir, R.L. Neuron (1990) [Pubmed]
  21. Regulation of the acetylcholine receptor epsilon subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation. Chu, G.C., Moscoso, L.M., Sliwkowski, M.X., Merlie, J.P. Neuron (1995) [Pubmed]
  22. Regulation of retrograde signaling at neuromuscular junctions by the novel C2 domain protein AEX-1. Doi, M., Iwasaki, K. Neuron (2002) [Pubmed]
  23. Primary sequence of a motor neuron-selective adhesive site in the synaptic basal lamina protein S-laminin. Hunter, D.D., Porter, B.E., Bulock, J.W., Adams, S.P., Merlie, J.P., Sanes, J.R. Cell (1989) [Pubmed]
  24. Aggregates of acetylcholinesterase induced by acetylcholine receptor-aggregating factor. Wallace, B.G., Nitkin, R.M., Reist, N.E., Fallon, J.R., Moayeri, N.N., McMahan, U.J. Nature (1985) [Pubmed]
  25. Molecular cloning of an invertebrate glutamate receptor subunit expressed in Drosophila muscle. Schuster, C.M., Ultsch, A., Schloss, P., Cox, J.A., Schmitt, B., Betz, H. Science (1991) [Pubmed]
  26. Physiological regulation of the immunological synapse by agrin. Khan, A.A., Bose, C., Yam, L.S., Soloski, M.J., Rupp, F. Science (2001) [Pubmed]
  27. New insights into the roles of agrin. Bezakova, G., Ruegg, M.A. Nat. Rev. Mol. Cell Biol. (2003) [Pubmed]
  28. The acetylcholine receptor at the neuromuscular junction. Peper, K., Bradley, R.J., Dreyer, F. Physiol. Rev. (1982) [Pubmed]
  29. Postsynaptic effects of ethanol at the frog neuromuscular junction. Bradley, R.J., Peper, K., Sterz, R. Nature (1980) [Pubmed]
  30. Action of formamidine pesticides on octopamine receptors. Evans, P.D., Gee, J.D. Nature (1980) [Pubmed]
  31. Calcium-dependent presynaptic action of substance P at the frog neuromuscular junction. Steinacker, A. Nature (1977) [Pubmed]
  32. Lithium reduces the number of acetylcholine receptors in skeletal muscle. Pestronk, A., Drachman, D.B. Science (1980) [Pubmed]
  33. Primary structure of dystrophin-related protein. Tinsley, J.M., Blake, D.J., Roche, A., Fairbrother, U., Riss, J., Byth, B.C., Knight, A.E., Kendrick-Jones, J., Suthers, G.K., Love, D.R. Nature (1992) [Pubmed]
  34. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M.P., Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, W.Y., De Mol, M., Wyns, S., Manka, D., Vermeulen, K., Van Den Bosch, L., Mertens, N., Schmitz, C., Robberecht, W., Conway, E.M., Collen, D., Moons, L., Carmeliet, P. Nat. Neurosci. (2005) [Pubmed]
  35. Postsynaptic requirement for Abl kinases in assembly of the neuromuscular junction. Finn, A.J., Feng, G., Pendergast, A.M. Nat. Neurosci. (2003) [Pubmed]
  36. Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Apel, E.D., Glass, D.J., Moscoso, L.M., Yancopoulos, G.D., Sanes, J.R. Neuron (1997) [Pubmed]
  37. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Perrier, A.L., Massoulié, J., Krejci, E. Neuron (2002) [Pubmed]
  38. Neuronal control of acetylcholine receptor turnover rate at a vertebrate neuromuscular junction. Levitt, T.A., Loring, R.H., Salpeter, M.M. Science (1980) [Pubmed]
  39. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Ohlendieck, K., Ervasti, J.M., Matsumura, K., Kahl, S.D., Leveille, C.J., Campbell, K.P. Neuron (1991) [Pubmed]
  40. Distribution of Na+ channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kd protein. Flucher, B.E., Daniels, M.P. Neuron (1989) [Pubmed]
  41. Synapsin I partially dissociates from synaptic vesicles during exocytosis induced by electrical stimulation. Torri Tarelli, F., Bossi, M., Fesce, R., Greengard, P., Valtorta, F. Neuron (1992) [Pubmed]
  42. Essential role of endophilin A in synaptic vesicle budding at the Drosophila neuromuscular junction. Guichet, A., Wucherpfennig, T., Dudu, V., Etter, S., Wilsch-Bräuniger, M., Hellwig, A., González-Gaitán, M., Huttner, W.B., Schmidt, A.A. EMBO J. (2002) [Pubmed]
WikiGenes - Universities